Cargando…

Antibody heavy chain CDR3 length-dependent usage of human IGHJ4 and IGHJ6 germline genes

Therapeutic antibody discovery using synthetic diversity has been proved productive, especially for target proteins not suitable for traditional animal immunization-based antibody discovery approaches. Recently, many lines of evidences suggest that the quality of synthetic diversity design limits th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huimin, Yan, Kai, Wang, Ruixue, Yang, Yi, Shen, Yuelei, Yu, Changyuan, Chen, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237691/ https://www.ncbi.nlm.nih.gov/pubmed/34195544 http://dx.doi.org/10.1093/abt/tbab010

Ejemplares similares

The Usage of Human IGHJ Genes Follows a Particular Non-random Selection: The Recombination Signal Sequence May Affect the Usage of Human IGHJ Genes
por: Shi, Bin, et al.
Publicado: (2020)

High-throughput sequencing of IgG B-cell receptors reveals frequent usage of the rearranged IGHV4–28/IGHJ4 gene in primary immune thrombocytopenia
por: Hirokawa, Makoto, et al.
Publicado: (2019)

Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course
por: Bagnara, Davide, et al.
Publicado: (2021)

VHH CDR-H3 conformation is determined by VH germline usage
por: Bahrami Dizicheh, Zahra, et al.
Publicado: (2023)

New insights into the germline genes and CDR3 repertoire of the TCRβ chain in Chiroptera
por: Zhou, Hao, et al.
Publicado: (2023)

Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding
por: D’Angelo, Sara, et al.
Publicado: (2018)

CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies
por: Fernández-Quintero, Monica L., et al.
Publicado: (2022)

Length-independent structural similarities enrich the antibody CDR canonical class model
por: Nowak, Jaroslaw, et al.
Publicado: (2016)

Dynamics of heavy chain junctional length biases in antibody repertoires
por: Sankar, Kannan, et al.
Publicado: (2020)

Adaption of human antibody λ and κ light chain architectures to CDR repertoires
por: van der Kant, Rob, et al.
Publicado: (2019)

CDR3 length in antigen-specific immune receptors
Publicado: (1994)

Multi Step Selection in Ig H Chains is Initially Focused on CDR3 and Then on Other CDR Regions
por: Liberman, Gilad, et al.
Publicado: (2013)

CDR2 antigen and Yo antibodies
por: Totland, Cecilie, et al.
Publicado: (2010)

Evolution of surrogate light chain in tetrapods and the relationship between lengths of CDR H3 and VpreB tails
por: Ott, Jeannine A., et al.
Publicado: (2022)

Highly Biased CDR3 Usage in Restricted Sets of β Chain Variable Regions During Viral Superantigen 9 Response
por: Ciurli, Cristina, et al.
Publicado: (1998)

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
por: Schubert, Manja, et al.
Publicado: (2014)

Antibody Heavy Chain Variable Domains of Different Germline Gene Origins Diversify through Different Paths
por: Kirik, Ufuk, et al.
Publicado: (2017)

Data on the nucleotide composition of the first codons encoding the complementary determining region 3 (CDR3) in immunoglobulin heavy chains
por: Thörnqvist, Linnea, et al.
Publicado: (2018)

Analysis of the CDR3 length repertoire and the diversity of T cell receptor α and β chains in swine CD4(+) and CD8(+) T lymphocytes
por: Wang, Chun-Yan, et al.
Publicado: (2017)

Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production
por: Ippolito, Gregory C., et al.
Publicado: (2006)

Canonical structures of short CDR-L3 in antibodies
por: Teplyakov, Alexey, et al.
Publicado: (2014)

Antibody Epitope Specificity for dsDNA Phosphate Backbone Is an Intrinsic Property of the Heavy Chain Variable Germline Gene Segment Used
por: Srdic-Rajic, Tatjana, et al.
Publicado: (2018)

Revisiting antibody modeling assessment for CDR-H3 loop
por: Nishigami, Hiroshi, et al.
Publicado: (2016)

Diversity in the Cow Ultralong CDR H3 Antibody Repertoire
por: Haakenson, Jeremy K., et al.
Publicado: (2018)

αβ T cell receptor germline CDR regions moderate contact with MHC ligands and regulate peptide cross-reactivity
por: Attaf, Meriem, et al.
Publicado: (2016)

The CLIC ILD CDR Geometry for the CDR Monte Carlo Mass Production
por: Muennich, A, et al.
Publicado: (2012)

Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration
por: Herdlevær, Ida, et al.
Publicado: (2020)

Expansion of B-1a Cells with Germline Heavy Chain Sequence in Lupus Mice
por: Holodick, Nichol E., et al.
Publicado: (2016)

CDR update report
por: Yin, Ting
Publicado: (2019)

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement
por: Berghaus, Natalie, et al.
Publicado: (2022)

Antibody humanization—the Influence of the antibody framework on the CDR-H3 loop ensemble in solution
por: Fernández-Quintero, Monica L, et al.
Publicado: (2019)

High-throughput sequencing analysis of genes encoding the B-lymphocyte receptor heavy-chain CDR3 in renal and peripheral blood of IgA nephropathy
por: Chen, Dapeng, et al.
Publicado: (2019)

PyIgClassify: a database of antibody CDR structural classifications
por: Adolf-Bryfogle, Jared, et al.
Publicado: (2014)

The CDR1 and Other Regions of Immunoglobulin Light Chains are Hot Spots for Amyloid Aggregation
por: Ruiz-Zamora, Robin Axel, et al.
Publicado: (2019)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
por: Boulard, Pierre, et al.
Publicado: (2022)

Antibody CDR amino acids underlying the functionality of antibody repertoires in recognizing diverse protein antigens
por: Peng, Hung-Pin, et al.
Publicado: (2022)

Analysis of the TCR alpha and beta chain CDR3 spectratypes in the peripheral blood of patients with Systemic Lupus Erythematosus
por: Luo, Wei, et al.
Publicado: (2008)

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration
por: Eichler, Tilo W., et al.
Publicado: (2013)

Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design
por: Svilenov, Hristo L., et al.
Publicado: (2021)

ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation
por: Abanades, Brennan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_43rhr7narn5o3saiftbrtbufq1